Mountain Valley MD Holdings Inc. Stock

Equities

MVMD

CA62430M1014

Pharmaceuticals

Delayed Canadian Securities Exchange 02:16:37 2024-04-25 pm EDT 5-day change 1st Jan Change
0.06 CAD -7.69% Intraday chart for Mountain Valley MD Holdings Inc. +20.00% +50.00%
Sales 2022 0.11 0.15 Sales 2023 - Capitalization 19.78M 27M
Net income 2022 -9M -12.29M Net income 2023 -7M -9.56M EV / Sales 2022 388,806,055 x
Net cash position 2022 14.18M 19.36M Net cash position 2023 9.71M 13.25M EV / Sales 2023 -
P/E ratio 2022
-5.09 x
P/E ratio 2023
-2.66 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.69%
More Fundamentals * Assessed data
Dynamic Chart
Mountain Valley MD Holdings Inc. Plans to Introduce Soluvec 1% Coated Fish Feed in Bangladesh by May of 2024 CI
Mountain Valley MD Holdings Inc. Provides Update on Agrarius Trial Results CI
Mountain Valley MD Holdings Inc.?s Contracted Manufacturing Partner in the U.S. Completes the Set-Up and Testing of Equipment to Enable the Proprietary Production of Nutraceutical Applications for MVMD?s Quicksome Technology, Including Sublingual Rapid Dissolve Tablets and Powders CI
Mountain Valley MD Holdings Inc. Announces CFO Changes CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Mountain Valley Says Yong Yao to Take Role of CFO in January MT
Mountain Valley MD Holdings Inc. Announces CFO Changes Effective January 15, 2024 CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Mountain Valley Appoints New CFO MT
Mountain Valley MD Holdings Inc. Announces Chief Financial Officer Changes CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Mountain Valley MD Holdings Inc. Announces Publication of Soluvec Trial Data in Therapeutic Delivery CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Mountain Valley MD Holdings Inc. Enters into A License Agreement with Ontario Corporation for Its Soluvec™1% Animal Husbandry Applications for the Territory of the People's Republic of Bangladesh CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
More news
1 day-7.69%
1 week+20.00%
1 month-7.69%
3 months+71.43%
6 months+50.00%
Current year+50.00%
More quotes
1 week
0.05
Extreme 0.05
0.07
1 month
0.05
Extreme 0.05
0.07
Current year
0.03
Extreme 0.03
0.08
1 year
0.03
Extreme 0.025
0.08
3 years
0.03
Extreme 0.025
1.09
5 years
0.03
Extreme 0.025
2.29
10 years
0.03
Extreme 0.025
2.29
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 18-11-30
General Counsel - -
Members of the board TitleAgeSince
Chief Executive Officer 52 18-11-30
Director/Board Member - 20-02-20
Director/Board Member 48 20-02-20
More insiders
Date Price Change Volume
24-04-25 0.06 -7.69% 84 175
24-04-24 0.065 +30.00% 281,704
24-04-23 0.05 -9.09% 6,204
24-04-22 0.055 0.00% 37,363
24-04-19 0.055 +10.00% 105,710

Delayed Quote Canadian Securities Exchange, April 25, 2024 at 02:16 pm EDT

More quotes
Mountain Valley MD Holdings Inc. is a Canada-based biotech company, which is focused on advancing solutions to optimize human, animal, and plant health. The Company is focused on implementation, licensing and reselling of key technologies and formulations, such as Quicksome oral formulation and delivery technologies, Quicksol solubility formulation technology, and Agrarius, a novel agricultural plant signaling technology. Quicksome technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats. Quicksol technology covers all solubilized macrocyclic lactones that could be applied in multiple viral applications that could impact human and animal health globally. Agrairus agricultural plant signaling technology is used as application to agricultural crops to naturally increase yields, reduce fertilizer usage, and enhance general resilience to pests and climate change.
More about the company